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Two chondroitin sulfate-containing complexes have been isolated from fetal bovine serum and shown to contain the serine protease inhibitor 
btkunin. A complex of 126 kDa contams bikunin linked by a chondroitm sulfate chain to a protein wrth homology to the HC2 component of the 
human inter-a-trypsin inhibitor. This complex represents the extracellular matrix stabilizing factor recently described as a bikunin-containing 
fraction necessary for expansion of the cumulus matrix [(1992) J. Biol. Chem. 267,12380-123861. A second complex of 236 kDa contains, in addition 
to bikunin and HC2, a bovine homolog of HC3 of the human pre-a-trypsin inhibitor. Thus, bovine bikunin is a chondrortin sulfate proteoglycan 
that achieves multifunctionality by linkage to proteins homologous to human serine antipioteinase complexes. 
Bikumn; Chondroitin sulfate proteoglycan: Carbohydrate crosslinking; Serme protease inhibitor 
1. INTRODUCTION of a second protease inhibitor known as pre-a-inhibitor 
Inter-a-trypsin inhibitor (IaI) is a serine protease in- 
hibitor first isolated from human plasma [l] where it is 
present at about 450 mg/l in healthy individuals [2] and 
rises markedly in several disease states [3]. It contains 
three subunits, the smallest of which (30 kDa) carries 
the protease inhibitory activity. This subunit consists of 
two pancreatic trypsin inhibitor-type (Kunitz) domains 
and has been named HI-30 [4] or bikunin [5]. In human 
serum, bikunin is associated with two distinct heavier 
chains of 65-70 kDa [4] termed HCl and HC2, that 
share 40% identity in their amino acid sequence [5]. A 
chondroitin sulfate chain links the three components 
into a 240 kDa complex; mild proteolysis of the Glu18- 
Val” bond of bikunin releases an HCl-HC2 dimer and 
extensive chondroitinase ABC treatment releases all 
three proteins [4]. The sequence around Ser” of bikunin 
(EEGSG) is a partial consensus sequence (DEXSG) for 
glycosaminoglycan addition and is thought to be the site 
for chondroitin sulfate attachment [4]. Therefore, 
bikunin is a proteoglycan attached by chondroitin sul- 
fate to HCl and HC2 through linkages of unknown 
chemical structure. 
(PaI). In studies with PaI, bikunin has been shown to 
carry a chondroitin4-sulfate chain on Ser” that is in- 
volved in a linkage with an 80 kDa protein named HC3 
[6]. The linkage is an unusual covalent ester bond be- 
tween the ol-carboxyl group of the C-terminal Asp of 
HC3 and a C-6 of an internal N-acetylgalactosamine 
residue of the chondroitin sulfate chain [6]. The occur- 
rence of similar linkages with HCl and HC2 has not to 
our knowledge been investigated. 
Human plasma bikunin also occurs as a component 
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It has recently been found that cumulus cells of the 
mouse ovarian follicle secrete a hyaluronan-rich matrix 
following ovulation, that can be observed in vitro fol- 
lowing stimulation with FSH and fetal bovine serum [7]. 
In the absence of serum, hyaluronan synthesis remains 
intact, but its retention in the matrix is impaired. A 
member of the IolI family with homology to the N- 
terminus of bikunin, when purified from bovine serum 
and added to minimal essential medium, was able to 
replace the serum requirement for matrix stabilization 
[7]. However, other trypsin inhibitors were unable to 
mimic the effect of IaI, and the anti-protease property 
of bikunin is not likely involved. Possibly this bovine 
extracellular matrix stabilizing factor (ESF) contains a 
bikunin proteoglycan that suits it for a role in the struc- 
tural assembly or cross-linking of cumulus matrix. Al- 
ternatively, an unrecognized function of other compo- 
nents of the bikunin complex(es) could be responsible 
for these observations. 
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Fig. 1. Coomassie blue-stained 7% SDS-PAGE of chondroitin sulphate-bikunin complexes obtained from fetal bovine serum. Lanes (a) and (b) 
represent a mixture of the two complexes before and after deglycosylation with triflouromethane sulphonic acid, respectively. Lane (c) is after a 
4 h treatment at 37’C with chondroitinase ABC, and lane (e) is after similar treatment with testicular hyaluronidase. Lanes (d) and (f) are 
chondroitinase ABC and hyaluromdase alone, respectively, at the same concentrations used in lanes (c) and (e). Left- and right-most lanes are 
prestained and unstained molecular mass markers, respectively. The complete gel is shown in the photograph; lighter material was allowed to run 
off the gel to achieve resolution of the higher molecular mass components. 
Here we report that bikunin in fetal calf serum occurs 
in two complexes, each linked by chondroitin sulfate. 
One is analogous to human Id but containing homol- 
ogs of HC2 and HC3 instead of HCl and HC2. The 
other, ESF, is a dimer of bikunin and HC2 with no 
evidence of HCl present. Interestingly, the first 20 resi- 
dues at the N-terminus of bovine HC2 differ from the 
human protein in eight positions, resulting in a tandom 
concensus sequence (SGESGE) for gly~osaminoglycan 
chain addition that nevertheless appears not to be gly- 
cosylated. 
2. MATERIALS AND METHODS 
2.1. Froteoglycan purdfcation 
Thirty ml of fetal bovine serum (Sigma, St. Louis, MO) was diluted 
to 200 ml with 50 mM Tris-HCI, 0.20 M NaCl, pH 8.0, and applied 
to a 2.0 ml DEAE-Sephacel column. After washing with 10 volumes 
of Tris buffer, proteoglycans were eluted with 5 volumes of 4 M 
guanidine-HCl, 50 mM sodium acetate, pH 5.8, and fractionated on 
Sephacryl S-300 (3 x 30 cm) in Tris buffer. Fractions between K,, of 
0 and 0.30 were collected, desalted, lyophylized. and separated by 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE) according to the procedure of Laemmli [S] on vertical poly- 
acrylamide slab gels (7 x 8 x 0.075 cm). Gel concentrations are indi- 
cated in the legends of the appropriate figures. Molecular mass protein 
standards (Bio-Rad, Mississauga, Ont.) were electrophoresed along 
with samples. 
2.2. Deglycosylation and enzyme digestion 
Samples were digested with 1 mIU of chondroitinase ABC (E.C. 
4.2.2.4; Sigma) in 10 ~1 of 50 mM Tris, 50 mM sodium acetate, pH 
7.5, or with 1 pug of testicular hyaluronidase (E.C. 3.2.1.35; Sigma) in 
10 ~1 of 50 mM Tris, 100 mM NaCl, I mM EDTA, pH 7,4, before 
electrophoresis. As preliminary experiments indicated some protease 
activity in both enzyme preparations, a panel of protease inhibitors 
was added to each digestion mixture (10 mM disodium EDTA. 5 mM 
benzamidine-HCI, 3 mM o-phenanthroline, 5 mM tryptamine-HCI, 
and 1 mM phenylmethylsulfonylfluoride, all from Sigma). Proteogly- 
cans were also deglycosylated using the method of Sojar et al. [9]. 
Briefly, 2Opl of trifluoromethane sulfonate (TFMS, Sigma) was added 
to the lyophilized samples under nitrogen atmosphere at 0°C. After 
1.5 h, the reaction was neutralized by adding drop wise to the reaction 
mixture 60 pl of 60% (v/v) aqueous pyridine chilled in dry ice/ethanol. 
The neutralized reaction mixture was eluted from Sepbadex G-50 in 
25 mM ammonium carbonate and the void volume fractions were 
pooled and lyophilized for electrophoresis. 
2.3. Sequence analysis and peptide mapping 
The electrophoretogram of the TFMS-deglycosylated proteogly- 
cans was electroblotted (TE22 Transphor; Hoefer Instruments, San 
Francisco, CA) to a ~lyvinylidine difluoride membrane (Bio-Rad), 
stained [lo] and sequenced using a Porton 2090 gas-phase microse- 
quencer (Porton Instruments; Tarzana, CA) with on-line analysis of 
phenylthiohydantoin derivatives. For the trypsin and cyanogen bro- 
mide digestion the samples were labelled with 0.2-1.0 mCi [‘*‘I]NaI 
(ICN; Irvine, CA) in IOOpl of 0.5 M phosphate buffer (pH 7.5). Each 
iodination reaction was initiated by the addition of one Iodo-Bead 
(Pierce, Rockford. IL). The tubes were capped and left at room tem- 
perature. After 15 min the reaction was terminated by removing the 
bead and free “‘1 was removed by desalting on Sephadex G-50/H,O. 
The iodinated sample was degIycosylated and electrophoresed as de- 
scribed above. The corresponding core protein bands on the gels were 
cut, crushed, electroeluted [I I] and desalted. Cyanogen bromide diges- 
tions were carried out in 20 fit of 70% formic acid containing 20 pg 
cyanogen bromide (J.T. Baker, Phillipsburg, NJ) overnight in the dark 
[12]. The digests were twice diluted to 0.5 ml and lyophilized for 
electrophoresis on 15% SDS-PAGE. Trypsin digestion was carried out 
with 0.25 pg of TPCK-treated trypsin (Srgma) in a total volume of 50 
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Fig. 2. SDS-PAGE (7%) autoradiogram of purified ~126 and ~236 
after radioiodination. Lanes (a,b): ~126. Lanes (c,d): ~236. Lanes (a,c): 
before deglycosylation with trifluoromethane sulfonic acid. Lanes 
(b,d): after deglycosylation. 
~1 for 2 h at 37°C. The digests were lyophilized before electrophoresis 
on 20% SDS-PAGE. The dried electrophoretogram was exposed to 
Kodak X-OMAT X-ray film at - 70°C overmght. 
3. RESULTS 
Matrix stabilizing factor from bovine serum has been 
found to be homologous to bikunin, which exists in 
human serum in complexes containing acidic glycosam- 
inoglycan. Partial purification of acidic components 
from fetal bovine serum by anion exchange chromatog- 
raphy provided two major protein bands of 126 kDa 
and 236 kDa on 1% SDS-PAGE under reducing condi- 
tions (Fig. l), designated ~126 and ~236. Deglycosyla- 
tion of the mixture with TFMS removes both these 
bands and gives rise to two major components of 82 and 
86 kDa. After electroelution and radioiodination, both 
glycoproteins re-chromatographed in their original po- 
sitions. On deglycosylation, the 86 kDa peptide was 
found to arise from ~126, whereas ~236 gave rise to the 
82 kDa peptide (Fig. 2). In addition, a 30 kDa compo- 
nent was liberated from both glycoproteins by TFMS 
treatment hat was observed on a 12.5% SDS-PAGE 
(not shown). Amino acid sequencing of the 30 kDa and 
86 kDa components derived from ~126 showed N-ter- 
minal homology with human bikunin and IolI-HC2, re- 
spectively (Table I). Sequencing of intact ~126 gave 
both N-terminal sequences in approximately equimolar 
amounts (Table II), consistent with a carbohydrate link- 
age of two separate peptides. The 82 kDa peptide from 
~236 shows 65% identity with human I&-HC3 in the 
N-terminal region (Table I). Although deglycosylation 
of iodinated ~236 gave rise only to 82 and 30 kDa 
components, sequencing of intact ~236 also revealed the 
presence of the N-terminal of the 86 kDa component of 
~126, and demonstrated that ~236 consists of one chain 
each of the homologs of human IaI components HC2, 
HC3 and bikunin (Table II). 
Treatment of the combined preparation of ~126 and 
~236 with chondroitinase ABC released components of 
82 and 86 kDa (Fig. 1) and 30 kDa (not shown). There- 
fore, the linkages in both complexes are chondroitim 
dermatan sulfate in nature. Similar results were ob- 
tained with testicular hyaluronidase which randomly 
cleaves the internal /I-N-acetylhexosamine-[1,4]-glyco- 
sidic bonds in hyaluronan and chondroitin sulfate. 
Human HC2 and HC3, and also HCl for which no 
bovine homolog was detected, are closely related pro- 
teins with considerable sequence identity that are never- 
theless products of distinct genes on separate chromo- 
somes [13]. The 86 and 82 kDa peptides described here 
as homologs of HC2 and HC3, respectively, also appear 
to be closely related as demonstrated by CNBr and 
tryptic fragmentation (Fig. 3). However, several unique 
bands in the CNBr-derived gel indicate that the proteins 
are distinct, and the smaller component is not a trun- 
cated version of the larger. 
Table I 
N-terminal ammo acid sequences obtained from purified 30, 82 and 
86 kDa proteins of fetal bovine serum bikunin-containing components 
The sequences of the homologous components of human IaI and Pa1 
[4] and ESF [7] are shown for comparison. A part of the sequence of 
the 30 kDa component (bold) was deduced by subtracting the known 
sequences of the 86 and 82 kDa proteins from the sequences of the 236 
kDa complex. Identical residues are boxed. 
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Fig. 3. Proteolysis patterns of the 82 and 86 kDa proteins associated with bikunin. Samples were run on 15% (a-d) or 20% (e-f) gels. Lanes (a,c,e,g): 
86 kDa protein. Lanes (b,d,f,h): 82 kDa protein. Lanes (a,b,e,f) are untreated samples, lanes (c,d) are after cyanogen bromide cleavage, and lanes 
(g,h) are after trypsinization. 
4. DISCUSSION 
Chen et al. [7] have described a factor from fetal 
bovine serum that serves as a stabilizing factor for the 
extracellular matrix (ESF) of the expanding cumulus in 
stimulated preovulatory follicles, without which hy- 
aluronan is not retained and normal ovulatory expan- 
sion does not occur. ESF was found to contain a protein 
homologous to bikunin, the inhibitory component of 
the human serine protease inhibitors IclI and PaI. The 
present study shows that bikunin occurs in at least two 
complexes - ~126 and ~236 - in fetal bovine serum, 
Table II 
Determination of subunit composition of ~236 and ~126 by sequenc- 
ing of the intact complexes 
Cycle #I Cycle #2 Cycle #3 
Complex Amino pmol Amino pmol Amino pm01 
acid acid acid 
~236 Serine 93 Isoleucine 35 Serine 35 
Alanine 40 Leucine 32 Proline 32 
Vahne 36 Leucine 32 
~126 Serine 
Alanine 
18 
11 
Isoleucine 
Valine 
12 Serine 12 
15 Leucine 13 
The first three cycles of Edman degradation are shown with the yield 
of amino acid given in pmol. Two sequences were obtained from the 
126 kDa complex and three from the 236 kDa complex. Sequencing 
was carried out for at least 10 additional cycles (not shown) and the 
deduced sequences were identified from those of the individual compo- 
nents m Table I. Amino acid yields are consistent with 1:1(:1) peptide 
chain stoichiometry. 
linked in each by a chondroitin sulfate chain to one or 
two larger proteins homologous to the ‘heavy chain’ 
peptides HC2 and HC3 of IaI and PclI, respectively. 
The smaller component, here designated ~126, corre- 
sponds to ESF. HCI, HC2 and HC3 are closely related 
proteins [13] that are associated with bikunin in human 
serum. Although the nature of the bikunin-HCI-HC2 
chondroitin sulfate linkages in IclI is not known, they 
may be similar to the bikunin-HC3 linkage of PC& 
namely conventional attachment of the glycosaminogly- 
can chain to Ser” of bikunin and a novel ester linkage 
between the glycosaminoglycan and the C-terminal of 
HC3 [6]. Based on the homologies described here, a 
model is proposed for the subunit arrangements of 
bikunin-containing complexes in both species (Fig. 4). 
Our sequence data indicate that Ser” of bovine bikunin 
is also glycosylated, and chondroitin sulfate is shown as 
a rigid polyelectrolyte chain attached to this position 
and to the C-termini of the heavy chains. 
The model emphasizes the absence of HCl in the 
bovine material and the presence of a common heavy 
chain (HC2) in the two forms of the bovine bikunin 
proteoglycan. Thus, whereas the human structures Ia1 
and Pa1 are distinct, the possibility exists that the bo- 
vine ~126 arises from ~236 by loss of HC3 or, alterna- 
tively, that ~126 represents incomplete synthesis of 
~236. The partial sequence similarity of the three 
human heavy chains [13] and the similar patterns of 
proteolysis of bovine HC2 and HC3 (Fig. 3) suggest 
that these species differences in subunit arrangement 
may not produce divergent functions. However, the 
functional significance of the heavy chains is not 
known, nor indeed is the basis of the matrix stabilizing 
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Fig. 4. Proposed model of the subunit arrangements of bovine ~126 
(also known as ESF) and ~236. Protein components are named for 
their homology with components of the human IccI and Pa1 complexes 
following the terminology of Enghild et al. [4]. The chondroitin sulfate 
chain (vertical bold l&e) is in extended conformation. Linkages are to 
the C-termini of the HC proteins and to Ser’O of both human and 
bovine bikunin (BiK). 
activity of ~126. Several other protease inhibitors were 
unable to substitute for ESF in stabilizing cumulus ma- 
trix [7] and a role of the non-bikunin components is 
indicated. The unusual linkages of the HC components 
to the proteoglycan bikunin may hold the proteins in a 
spatial arrangement that facilitates a crosslinking func- 
tion. 
The failure to observe the 86 kDa HC2 protein by 
autoradiography after iodination and deglycosylation 
of ~236 (Fig. 2) requires comment. Its presence in stoi- 
chiometric amounts was demonstrated by sequencing 
(Table II) and a second chain is necessary to account for 
the mass of ~236. HC2 may be destabilized by iodina- 
tion and more fully degraded by TFMS under the con- 
ditions for extensive deglycosylation employed in Fig. 
2. Alternatively, partial degradation could lead to fail- 
ure to resolve the two components. 
In summary, bovine bikunin is a chondroitin sulfate 
proteoglycan that achieves multifunctionality by virtue 
of its association with a family of related heavy chain 
proteins. Matrix stabilizing function may reside in these 
heavy chains, or in the spatial arrangement dictated by 
their disposition along the glycosaminoglycan chain. In 
this regard, it will be interesting to determine if matrix- 
stabilizing activity is also associated with ~236. 
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